Impact of COVID-19 Outbreak on Vaccine for Influenza, Global Market Research Report 2020

1 Vaccine for Influenza Market Overview

• 1.1 Product Overview and Scope of Vaccine for Influenza
• 1.2 Covid-19 Impact on Vaccine for Influenza Segment by Type
  • 1.2.1 Global Vaccine for Influenza Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Trivalent Influenza Vaccine
  • 1.2.3 Quadrivalent Influenza Vaccine
• 1.3 Covid-19 Impact on Vaccine for Influenza Segment by Application
  • 1.3.1 Vaccine for Influenza Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 For Children (6 months to 3 years)
  • 1.3.3 For Adults and Children over 3 years
• 1.4 Covid-19 Impact on Global Vaccine for Influenza Market Size Estimates and Forecasts
  • 1.4.1 Global Vaccine for Influenza Revenue 2015-2026
  • 1.4.2 Global Vaccine for Influenza Sales 2015-2026
  • 1.4.3 Vaccine for Influenza Market Size by Region: 2020 Versus 2026
• 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
  • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  • 1.5.2 Covid-19 Impact: Commodity Prices Indices
  • 1.5.3 Covid-19 Impact: Global Major Government Policy
• 1.6 The Covid-19 Impact on Vaccine for Influenza Industry
• 1.7 COVID-19 Impact: Vaccine for Influenza Market Trends

2 Covid-19 Impact on Global Vaccine for Influenza Market Competition by Manufacturers

• 2.1 Global Vaccine for Influenza Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Vaccine for Influenza Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Vaccine for Influenza Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Vaccine for Influenza Manufacturing Sites, Area Served, Product Type
• 2.5 Vaccine for Influenza Market Competitive Situation and Trends
  • 2.5.1 Vaccine for Influenza Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Vaccine for Influenza Players (Opinion Leaders)

3 Covid-19 Impact on Vaccine for Influenza Retrospective Market Scenario by Region

• 3.1 Global Vaccine for Influenza Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Vaccine for Influenza Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Vaccine for Influenza Market Facts & Figures by Country
  • 3.3.1 North America Vaccine for Influenza Sales by Country
  • 3.3.2 North America Vaccine for Influenza Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Vaccine for Influenza Market Facts & Figures by Country
  • 3.4.1 Europe Vaccine for Influenza Sales by Country
  • 3.4.2 Europe Vaccine for Influenza Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Vaccine for Influenza Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Vaccine for Influenza Sales by Region
  • 3.5.2 Asia Pacific Vaccine for Influenza Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Vaccine for Influenza Market Facts & Figures by Country
  • 3.6.1 Latin America Vaccine for Influenza Sales by Country
  • 3.6.2 Latin America Vaccine for Influenza Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Vaccine for Influenza Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Vaccine for Influenza Sales by Country
  • 3.7.2 Middle East and Africa Vaccine for Influenza Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Covid-19 Impact on Global Vaccine for Influenza Historic Market Analysis by Type

• 4.1 Global Vaccine for Influenza Sales Market Share by Type (2015-2020)
• 4.2 Global Vaccine for Influenza Revenue Market Share by Type (2015-2020)
• 4.3 Global Vaccine for Influenza Price Market Share by Type (2015-2020)
• 4.4 Global Vaccine for Influenza Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Covid-19 Impact on Global Vaccine for Influenza Historic Market Analysis by Application

• 5.1 Global Vaccine for Influenza Sales Market Share by Application (2015-2020)
• 5.2 Global Vaccine for Influenza Revenue Market Share by Application (2015-2020)
• 5.3 Global Vaccine for Influenza Price by Application (2015-2020)

6 Company Profiles and Key Figures in Vaccine for Influenza Business

• 6.1 Sanofi
  • 6.1.1 Corporation Information
  • 6.1.2 Sanofi Description, Business Overview and Total Revenue
  • 6.1.3 Sanofi Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Sanofi Products Offered
  • 6.1.5 Sanofi Recent Development and Response to COVID-19
• 6.2 CSL
  • 6.2.1 CSL Corporation Information
  • 6.2.2 CSL Description, Business Overview and Total Revenue
  • 6.2.3 CSL Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 CSL Products Offered
  • 6.2.5 CSL Recent Development and Response to COVID-19
• 6.3 GSK
  • 6.3.1 GSK Corporation Information
  • 6.3.2 GSK Description, Business Overview and Total Revenue
  • 6.3.3 GSK Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 GSK Products Offered
  • 6.3.5 GSK Recent Development and Response to COVID-19
• 6.4 Mylan
  • 6.4.1 Mylan Corporation Information
  • 6.4.2 Mylan Description, Business Overview and Total Revenue
  • 6.4.3 Mylan Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Mylan Products Offered
  • 6.4.5 Mylan Recent Development and Response to COVID-19
• 6.5 Hulan Bio
  • 6.5.1 Hulan Bio Corporation Information
  • 6.5.2 Hulan Bio Description, Business Overview and Total Revenue
  • 6.5.3 Hulan Bio Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Hulan Bio Products Offered
  • 6.5.5 Hulan Bio Recent Development and Response to COVID-19
• 6.6 AstraZeneca
  • 6.6.1 AstraZeneca Corporation Information
  • 6.6.2 AstraZeneca Description, Business Overview and Total Revenue
  • 6.6.3 AstraZeneca Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 AstraZeneca Products Offered
  • 6.6.5 AstraZeneca Recent Development and Response to COVID-19
• 6.7 CCBIO
  • 6.6.1 CCBIO Corporation Information
  • 6.6.2 CCBIO Description, Business Overview and Total Revenue
  • 6.6.3 CCBIO Vaccine for Influenza Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 CCBIO Products Offered
  • 6.7.5 CCBIO Recent Development and Response to COVID-19

7 Vaccine for Influenza Manufacturing Cost Analysis

• 7.1 Vaccine for Influenza Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Vaccine for Influenza
• 7.4 Vaccine for Influenza Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Vaccine for Influenza Distributors List
• 8.3 Vaccine for Influenza Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Vaccine for Influenza Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Vaccine for Influenza by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Vaccine for Influenza by Type (2021-2026)
• 10.2 Vaccine for Influenza Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Vaccine for Influenza by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Vaccine for Influenza by Application (2021-2026)
• 10.3 Vaccine for Influenza Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Vaccine for Influenza by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Vaccine for Influenza by Region (2021-2026)
• 10.4 North America Vaccine for Influenza Estimates and Projections (2021-2026)
• 10.5 Europe Vaccine for Influenza Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Vaccine for Influenza Estimates and Projections (2021-2026)
• 10.7 Latin America Vaccine for Influenza Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Vaccine for Influenza Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List